Introduction of inactivated poliovirus vaccine leading into the polio eradication endgame strategic plan; Hangzhou, China, 2010–2014
- 1 March 2017
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 35 (9), 1281-1286
- https://doi.org/10.1016/j.vaccine.2017.01.034
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Progress Toward Polio Eradication — Worldwide, 2015–2016Morbidity and Mortality Weekly Report (MMWR), 2016
- Modeling Options to Manage Type 1 Wild Poliovirus Imported Into Israel in 2013The Journal of Infectious Diseases, 2014
- Modeling the Potential Role of Inactivated Poliovirus Vaccine to Manage the Risks of Oral Poliovirus Vaccine CessationThe Journal of Infectious Diseases, 2014
- Vaccine-Associated Paralytic Poliomyelitis: A Review of the Epidemiology and Estimation of the Global BurdenThe Journal of Infectious Diseases, 2014
- Identification and Control of a Poliomyelitis Outbreak in Xinjiang, ChinaThe New England Journal of Medicine, 2013
- Modeling Population Immunity to Support Efforts to End the Transmission of Live PoliovirusesRisk Analysis, 2012
- Molecular characterization of poliovirus isolates from children who contracted vaccine-associated paralytic poliomyelitis (VAPP) following administration of monovalent type 3 oral poliovirus vaccine in the 1960s in HungaryFEMS Immunology & Medical Microbiology, 2010